Clinical Trial Update: Curative Efficacy of Pravastatine in Patients Presented Delayed Cutaneous and Subcutaneous Radio-induced Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial updating the curative efficacy of pravastatine in patients with delayed cutaneous and subcutaneous radio-induced fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrosis

Drugs mentioned

• pravastatine (pravastatin)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Fibrosis | Phase 2 | Status: COMPLETED